SWITCH Trial retweeted
Innovation happens when science and industry collide. Join our Innovation Session and Village at ESOC 2027 in Vienna. Be part of the future!
@ESOstroke @carlosmictusvh @Simona_Sacco_
🚀 The ESOC Innovation Session returns to #ESOC2027! More opportunities to showcase ideas, connect with the #Stroke community & drive innovation in #StrokeCare.
New: Dedicated innovation village & networking space!
🔗 ow.ly/b9VV5105I4A
@carlosmictusvh @FishingNeurons
SWITCH Trial retweeted
📢 Advance #StrokeScience & submit your abstract for #ESOC2027: 🔗 ow.ly/Espo5101CNQ
⏰ Deadlines: 9 January 2027 for general topics & 25 February 2027 for ongoing trials.
Late-breaking abstract submissions open on 20 January 2027.
#VoiceOfStroke #Stroke #Neurology
SWITCH Trial retweeted
Deeply honored to represent the ESO - European Stroke Organisation at the World Stroke Organisation Conference in Seoul! Many thanks for joining global forces to reduce the burden of stroke.
@ESOstroke @Diana_A_Sousa @GiseleSampaioS @ArKatsanos
🌍 Advancing stroke care together!
At #WSC2026 in Seoul, ESO & @WorldStrokeOrg joined forces for a session exploring the next frontiers in #stroke prevention, ICH, venous sinus thrombosis & acute stroke management.
🤝 Driving science forward through global collaboration!
SWITCH Trial retweeted
Interesting podcast on the latest evidence on endovascular stroke treatment on people with medium or distal vessel occlusion stroke! @DistalTrial @MPeyT1 @unibern
🎙️ What are the “green flags” for thrombectomy in medium or distal vessel occlusion? #VoiceOfStroke explores #Stroke severity, collateral status & evidence that successful reperfusion can preserve threatened brain tissue.
Listen now:
🍎 Apple: ow.ly/IgbA50ZPZSL
SWITCH Trial retweeted
Many thanks to the SAPE leadership team for their amazing efforts to improve stroke care throughout Europe! Implementation of effective stroke treatment strategies is key to reduce the burden of stroke in Europe!
Two inspiring days with the leadership of the #StrokeActionPlan for Europe 🧠💙
Tackling challenges & planning the next steps towards 2030 – united by one goal: Reducing the burden of stroke and improving stroke care across Europe.
Together, we can make a difference.
SWITCH Trial retweeted
Two inspiring days with the leadership of the #StrokeActionPlan for Europe 🧠💙
Tackling challenges & planning the next steps towards 2030 – united by one goal: Reducing the burden of stroke and improving stroke care across Europe.
Together, we can make a difference.
SWITCH Trial retweeted
💡Already day 3 of the ESO Summer School in Lisbon!
Today: Update on 3Stroke Management
From prevention and acute treatment to rehabilitation, imaging and digital technologies – another full day of expert updates, discussions and hands-on workshop learning.
#StrokeEducation
SWITCH Trial retweeted
🎥 In this #ESOC2026 TV Studio session, @FishingNeurons and @johanna_ospel discuss medium and distal vessel occlusions, patient selection, clinical outcomes and the future of endovascular treatment.
▶️ Dive into the discussion: ow.ly/txNX50Zf5sf
#VoiceOfStroke #Stroke
SWITCH Trial retweeted
Treatment of people with a stroke due to medium and distal vessel occlusion remains a big challenge. Further evidence is needed. Our MANAGE-DISTAL trial aims to answer the remaining questions in acute stroke management! @TECNO_Trial @DistalTrial
ESO’s #PaperOfTheMonth: Endovascular treatment for medium or distal vessel occlusion stroke (DISTAL): 12-month outcomes of a multicentre, open-label, randomised trial
👉 Read more here:🔗ow.ly/XCg750Zc9RR
#StrokeScience @FishingNeurons @marcriboj @_federica_rizzo
SWITCH Trial retweeted
ESO’s #PaperOfTheMonth: Endovascular treatment for medium or distal vessel occlusion stroke (DISTAL): 12-month outcomes of a multicentre, open-label, randomised trial
👉 Read more here:🔗ow.ly/XCg750Zc9RR
#StrokeScience @FishingNeurons @marcriboj @_federica_rizzo
SWITCH Trial retweeted
A successful joint session with the Chinese Stroke Association at #TISC2026 in Beijing 🇨🇳 saw leading experts from Europe and China discuss the future of acute ischemic stroke care.
We look forward to further strengthen our collaboration to improve stroke care worldwide.
#Stroke
SWITCH Trial retweeted
Honoured and very grateful for this recognition. More than a personal distinction, I see it as a reflection of the collective work of the many colleagues I have had the privilege of working with.
My sincere thanks to everyone who has been part of this journey. @ESOstroke
🔬 Scientific Excellence Award
Celebrating @Diana_A_Sousa, winner of the Scientific Excellence Award!
Thank you for advancing the frontiers of stroke science and care.
#ESOC2026 #VoiceOfStroke #Stroke #StrokeResearch #StrokeScience
SWITCH Trial retweeted
🧵1/6 Exciting results from the #TECNO trial presented at @ESOstroke in Maastricht 🇳🇱
Despite successful thrombectomy, up to ~40% of patients have incomplete reperfusion (TICI <3) and worse outcomes.
Can administering intra-arterial thrombolysis after EVT help❓️
#ESOC2026
SWITCH Trial retweeted
Congratulations to all!!!
We welcome the new ESO Executive Committee. Congratulations to @FishingNeurons as President & Robin Lemmens as President-Elect. A warm welcome to new members @HanneKChr & Pierre Seners.
We extend our thanks to @Simona_Sacco_ for her leadership during her term as ESO President.
SWITCH Trial retweeted
Intra-arterial Alteplase After Thrombectomy for Acute Ischemic Stroke jamanetwork.com/journals/jam…
SWITCH Trial retweeted
We welcome the new ESO Executive Committee. Congratulations to @FishingNeurons as President & Robin Lemmens as President-Elect. A warm welcome to new members @HanneKChr & Pierre Seners.
We extend our thanks to @Simona_Sacco_ for her leadership during her term as ESO President.
SWITCH Trial retweeted
📺 ESOC 2026 TV Highlights, Thu 7 May.
12:45 – Trials with @manonkappelhof, @gerritgrosse, Götz Thomalla & @PrCCordonnier.
13:00 – Vessel occlusion update with Urs Fischer & @johanna_ospel
🔗 eso-stroke.org/esoc2026
#ESOC2026
SWITCH Trial retweeted
Excellent investigators meeting of our @DOIT_trial at ESOC2026! The room was fully packed and many people were online. Congratulations to Thomas Meinel and Luciana Catanese for the amazing leadership!
SWITCH Trial retweeted
Endovascular treatment for medium or distal vessel occlusion stroke (D... sciencedirect.com/science/ar…
SWITCH Trial retweeted
Is ATLAS lifting the burden of stroke in people with large-vessel occlusion and low ASPECTS scores? - The Lancet thelancet.com/journals/lance…